Table 7. Changes in corneal fluorescein score following exosomes treatment.
| Study | DED model type and treatment route |
DED treated with Exosomes |
DED given PBS/saline |
Absolute difference between PBS group and exosomes |
Healthy control |
Absolute difference between exosome and healthy control |
|---|---|---|---|---|---|---|
| Tian et al. 2023 * |
C57BL/6 mice BAC model, topical | MSC-Exo; 6MSC-Exo- Ce; 2 |
12.5 | 10.5−6.5 | 0.5 | 1.5−5.5 |
| Ma et al.2023 * |
C57BL/6 mice BAC model, topical | mExo; 7.5mExo@AA; 4 |
15 | 7.5−11 | 1 | 3−6.5 |
| Wang et al. 2022* |
C57BL/6 mice BAC model, topical | 1.8 | 3.5 | 1.7 | 0.5 | 1.3 |
| Guo et al. 2022 * |
C57BL/6 mice BAC model, topical | 3 | 5 | 2 | 0.5 | 2.5 |
| Wang et al.2023 * |
C57BL/6 mice BAC model, topical | 2 in 3.0 mg/mL Exo group | 8 | 6 | N/A | |
| Yu et al.2020 | C57BL/6 mice BAC model, topical | 5.2 | 12.0 | 6.8 | 1.2 | 4 |
Values obtained from the graph as no absolute values given in the article
DED- Dry Eye Disease, PBS − Phosphate Buffer Solution, BAC − Benzalkonium Chloride, MSC − Mesenchymal Stem Cell